Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -30.34x is 69% above its 5-year average of -96.32x, near the high end of its 5-year range (-685.37x–-4.91x).
9.00% above its 12-month average of -33.34x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -60.89x.
INTEREST COVERAGE RATIO
-30.34x
INTEREST COVERAGE RATIO AVG TTM
-33.34x
INTEREST COVERAGE RATIO AVG 3Y
-46.84x
INTEREST COVERAGE RATIO AVG 5Y
-96.32x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+9.00%
CURRENT VS 3Y AVG
+35.22%
CURRENT VS 5Y AVG
+68.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-371.12%
vs the sector median at left
Definium Therapeutics, Inc.
Market Cap
$4.73B
Interest Coverage Ratio
-30.34x
TTM Avg
-33.34x
3Y Avg
-46.84x
5Y Avg
-96.32x
Market Cap
$4.70B
Interest Coverage Ratio
2.07x
TTM Avg
2.07x
3Y Avg
2.07x
5Y Avg
1.38x
Market Cap
$4.78B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.64B
Interest Coverage Ratio
5.35x
TTM Avg
5.33x
3Y Avg
5.03x
5Y Avg
4.13x
Market Cap
$4.83B
Interest Coverage Ratio
-1.54x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.84B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.60B
Interest Coverage Ratio
168.66x
TTM Avg
168.66x
3Y Avg
168.66x
5Y Avg
168.66x
Market Cap
$4.48B
Interest Coverage Ratio
5.89x
TTM Avg
3.33x
3Y Avg
3.33x
5Y Avg
4.95x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | $4.73B | -30.34x | -33.34x | -46.84x | -96.32x |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 2.07x | 2.07x | 2.07x | 1.38x |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.78B | N/A | N/A | N/A | N/A |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 5.35x | 5.33x | 5.03x | 4.13x |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.83B | -1.54x | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.84B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 168.66x | 168.66x | 168.66x | 168.66x |
| Erasca, Inc. (ERAS)vs › | $4.96B | N/A | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.48B | 5.89x | 3.33x | 3.33x | 4.95x |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 3.22x | 2.04x | 1.33x | 1.16x |
Interest Coverage
-30.3x
Debt/Equity
0.04
Current Ratio
6.95
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -60.89x |
| 2026-03-31 | -47.57x |
| 2025-12-31 | -4.91x |
| 2025-09-30 | -35.85x |
| 2025-06-30 | -17.49x |
| 2025-03-31 | -53.42x |
| 2024-12-31 | -49.48x |
| 2024-09-30 | -34.10x |
| 2024-06-30 | -52.48x |
| 2024-03-31 | -51.16x |
| 2023-09-30 | -65.90x |
| 2023-06-30 | -379.01x |
| 2023-03-31 | -274.50x |
| 2022-03-31 | -685.37x |
| 2021-12-31 | -48.91x |
| 2021-09-30 | -269.17x |
| 2021-06-30 | -655.36x |
| 2020-12-31 | -201.40x |
| 2019-08-31 | -767.70x |
